Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian share markets open in the green
Fri, 23 May 09:30 am

The major Asian stock markets have opened the day on a mixed note with stock markets in Japan (up 1.2%) and Singapore (up 0.2%) leading the gains. However, stock markets in Hong Kong (down 0.1%) and Malaysia (down 0.1%) have opened in the red. The Indian share markets have opened the day on a firm note. All sectoral indices have opened in the green with the stocks in the realty and auto space leading the gains.

The Sensex today is up by around 150 points (0.6%), while the NSE-Nifty is up by about 30 points (0.4%). The midcap and smallcap stocks have also opened in the green with BSE Mid Cap and BSE Small Cap indices up by around 1.2% and 1.5% respectively. The rupee is currently trading at Rs 58.44 to the US dollar.

Auto stocks have opened mainly in the green with TVS Motors Ltd and Maruti Suzuki Ltd leading the gains. However, Tata Motors Ltd and Hero Motocorp Ltd were facing selling pressure. Ashok Leyland and has announced results for the quarter ended March 2014. The company has reported a decline of 17.5% YoY during the quarter in the revenues. As per the management, the company has restructured itself to face the challenges in a tough year and to reduce overall fixed cost. In FY14, the company was able to retain market share in an highly competitive medium and heavy commercial vehicle market that witnessed a decline of over 25% second year in a row. The net profit for the quarter was up 142% YoY, mainly on account of exceptional items, including selling of non-core assets. The debt to equity ratio at the end of March 2014 stood at 1.14:1. The company aims to reduce it to 1:1 by end of March 2014.

MNC Pharma stocks have opened the day mainly in the green with Abbott India Ltd and Sanofi India Ltd leading the gains. Novartis India has reported results for the quarter ended March 2014. The revenues during the quarter declined by 5.7% YoY during the quarter. As per the management, this was mainly due to reduction in selling prices of some key products arising out of the notification of the new Drug Prices Control Order. The company has reported a decline of 2.2% YoY in the net profit during the quarter. Rupee depreciation made things even worse for the company. The company's Board has approved dividend recommendation of Rs.10 per equity share of Rs.5 each for the year ended on 31 March 2014.

What would be the best sector to invest in given the current scenario and looking at the next 3-4 years period? Share your views on Equitymaster Club Share your views on Equitymaster Club

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian share markets open in the green". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.